Exploration of the immunogenetic landscape of hyperprogressive disease after combined immunotherapy in cancer patients

The immune-genetic changes that occur in cancer patients experiencing hyperprogressive disease (HPD) during combined immunotherapy are unclear. In this study, HPD patients with pre- and post-HPD samples and non-HPD patients with solid tumors were molecularly characterized by genetic and tumor immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Caifeng, Zhang, Wen, Sun, Yongkun, Shou, Jianzhong, Jiang, Zhichao, Liu, Tianyi, Wang, Shengzhou, Liu, Jun, Sun, Ying, Zhou, Aiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225883/
https://www.ncbi.nlm.nih.gov/pubmed/37255657
http://dx.doi.org/10.1016/j.isci.2023.106720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225883/
https://www.ncbi.nlm.nih.gov/pubmed/37255657
http://dx.doi.org/10.1016/j.isci.2023.106720

Ejemplares similares